Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY4 known ✓ | P51582 | 10/20 | 0.67 |
| ▸ | P2RY2 known ✓ | P41231 | 8/20 | 0.67 |
| ▸ | P2RY12 known ✓ | Q9H244 | 6/20 | 0.60 |
| ▸ | P2RY6 known ✓ | Q15077 | 1/20 | 0.57 |
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.55 |
| ▸ | P2RY1 known ✓ | P47900 | 2/20 | 0.55 |
| ▸ | MET | P08581 | 2/20 | 0.57 |
| ▸ | CDK2 | P24941 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | NSD2 | O96028 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350751 | 1.00 | P2RY4 (0.67) | P2RY4P2RY2P2RY12METP2RY6 | |
| Hydrochloric Acid SCHEMBL30808003 | 0.99 | P2RY4 (0.65) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL29637834 | 0.95 | P2RY4 (0.61) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL30106754 | 0.95 | P2RY4 (0.61) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL30311409 | 0.93 | P2RY4 (0.59) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL29354251 | 0.93 | P2RY4 (0.59) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL185515 | 0.93 | P2RY4 (0.59) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL2343041 | 0.92 | P2RY4 (0.58) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL29375867 | 0.90 | P2RY4 (0.56) | P2RY4P2RY2P2RY12METP2RY6 | |
| SCHEMBL2861363 | 0.90 | P2RY4 (0.56) | P2RY4P2RY2P2RY12METP2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2930126-B1 | Fashionable aerosol dye | HENKEL AG & CO KGAA (DE) | 2019-10-09 | — | — | EP | claimed |
| US-9296901-B2 | Composite particles, and coloring composition and resin composition using the same | TODA KOGYO CORPORATION (JP) | 2016-03-29 | — | — | US | claimed |
| EP-2544723-A2 | COMPOSITIONS FOR COLON LAVAGE AND METHODS OF MAKING AND USING SAME | Giuliani International Limited (IE) | 2013-01-16 | — | — | EP | claimed |
| WO-2011110347-A2 | COMPOSITIONS FOR COLON LAVAGE AND METHODS OF MAKING AND USING SAME | GIULIANI INTERNATIONAL LIMITED (IE) | 2011-09-15 | — | — | WO | claimed |
| CN-1295957-C | Treating method of plant leaf to be preserved | NIKEN LANTACOM CO LTD (JP) | 2007-01-24 | — | — | CN | claimed |
| CN-1398512-A | Treating method of plant leaf to be preserved | NIKEN LANTACOM CO LTD (JP) | 2003-02-26 | — | — | CN | claimed |
| WO-2002046741-A1 | ELAPSED TIME INDICATOR | CHROMA CFHEM PTY LTD. (AU) | 2002-06-13 | — | — | WO | claimed |
| US-5618733-A | IONIC SURFACTANT FOR LYSING ERYTHROCYTES AND CAUSING DAMAGE TO LEUKOCYTE CELL MEMBRANES, ORGANIC COMPOUND HAVING ACIDIC GROUP | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1997-04-08 | — | — | US | claimed |
| CN-122059518-A | Application of lignin-based flocculant in treatment of wastewater containing anionic dye | 中国人民大学 | 2026-05-19 | — | — | CN | disclosed |
| US-20260048043-A1 | HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY | INTELGENX CORP (CA) | 2026-02-19 | — | — | US | disclosed |
| EP-4325272-B1 | HEAD-UP DISPLAY SYSTEM | FUYAO GLASS IND GROUP CO LTD (CN) | 2025-10-01 | — | — | EP | disclosed |
| EP-4578919-A1 | AQUEOUS INK COMPOSITION FOR WRITING INSTRUMENTS, AND WRITING INSTRUMENT HOUSING SAME | Kabushiki Kaisha Pilot Corporation (also trading as Pilot Corporation) (JP) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025129358-A1 | STABLE FILM FORMULATIONS FOR HIGH LOADING OF LOW MELTING POINT ACTIVES | INTELGENX CORP. (CA) | 2025-06-26 | — | — | WO | disclosed |
| EP-4568671-A1 | HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY | Intelgenx Corp. (CA) | 2025-06-18 | — | — | EP | disclosed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | disclosed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | disclosed |
| US-5098608-A | Heat resistant and storage stable detergents | SHISEIDO COMPANY LTD. (JP) | 1992-03-24 | — | — | US | disclosed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | disclosed |
| EP-0426984-A2 | Transparent solid detergent composition | SHISEIDO COMPANY LIMITED (JP) | 1991-05-15 | — | — | EP | disclosed |
| US-5015263-A | Composition for coloring skin and method | CLAIROL INCORPORATED (US) | 1991-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048043-A1 | HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY | MUC1, TAS2R42, MTX2 | P2RY4 2379/4885P2RY2 1989/4885P2RY12 2354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.